Product correctly added to cart.

discount label
Sr-3306
View 3D

Biosynth logo

Sr-3306

CAS: 1128096-91-2

Ref. 3D-DVB09691

5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Monday 13 Jan 2025

Product Information

Name:
Sr-3306
Description:

Sr-3306 is a nonsteroidal anti-inflammatory drug (NSAID) that is the active form of the prodrug sulfasalazine. It inhibits prostaglandin synthesis by blocking cyclooxygenase (COX) activity and preventing the conversion of arachidonic acid to prostaglandins, which are important mediators of inflammation. Sr-3306 also inhibits COX-2 expression through a variety of mechanisms, including inhibition of NF-κB signaling pathways and activation of peroxisome proliferator-activated receptor gamma (PPARγ). It has been shown to inhibit cell growth in cancer cells and has neuroprotective effects against dopamine toxicity in animal models. In addition, it has been shown to inhibit epidermal growth factor (EGF), which causes inflammation and tumorigenesis, as well as inhibitory effects on the development of acute ischemic stroke.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
490.56 g/mol
Formula:
C28H26N8O
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-DVB09691 Sr-3306

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".